Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Holding SLNO?
Track your performance easily

Soleno Therapeutics (SLNO) Income Statement

707 Followers

Soleno Therapeutics Income Statement

Last quarter (Q2 2024), Soleno Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Soleno Therapeutics's net income was $-21.85M. See Soleno Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 67.35M$ 41.38M$ 24.40M$ 31.53M$ 31.95M$ 23.20M
Operating Income
$ -66.72M$ -41.38M$ -24.40M$ -31.53M$ -31.95M$ -23.20M
Net Non Operating Interest Income Expense
$ 5.09M---$ 13.00K$ 154.00K
Other Income Expense
$ 331.00K$ -2.40M$ -330.00K$ -618.00K$ 7.30M$ -7.73M
Pretax Income
$ -57.88M$ -33.56M$ -25.49M$ -30.91M$ -24.64M$ -30.77M
Tax Provision
-$ -505.00K$ -527.00K$ 2.34M--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -62.59M$ -39.00M$ -25.49M$ -30.91M$ -24.64M$ -30.77M
Basic EPS
$ -2.92$ -2.36$ -2.87-$ -0.39$ -0.90
Diluted EPS
$ -2.92$ -2.36$ -2.87$ -5.85$ -0.39$ -0.90
Basic Average Shares
$ 96.70M$ 16.49M$ 8.40M$ 5.32M$ 62.62M$ 34.14M
Diluted Average Shares
$ 96.70M$ 16.49M$ 8.40M$ 5.32M$ 62.62M$ 34.14M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 67.35M$ 41.38M$ 24.40M$ 31.53M$ 31.95M$ 23.20M
Net Income From Continuing And Discontinued Operation
$ -62.59M$ -39.00M$ -24.10M$ -30.91M$ -24.64M$ -30.77M
Normalized Income
$ -53.97M-$ -26.02M-$ -31.94M$ -23.52M
Interest Expense
------
EBIT
$ -59.52M$ -34.06M$ -25.49M$ -30.91M$ -31.95M$ -23.20M
EBITDA
$ -50.20M$ -32.11M$ -23.53M$ -28.95M$ -30.00M$ -21.24M
Currency in USD

Soleno Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis